Investors target Chinese cancer drugs

Drug developers such as I-Mab are trying to lead the market and secure future cash flow with their technological progress.

Investors target Chinese cancer drugs

The search for anti-cancer drugs has strong support from the Chinese government which has spurred investors to pour money into the sector. What's hot this year seems to be immuno-oncology and the related field of precision medicine.

Traditional chemotherapy indiscriminately attacks cells, whether they are cancerous or not. But more advanced oncology treatments seek to activate a body's own immune system to destroy cancer cells. This is called immuno-oncology I-O, which is...

FinanceAsia has updated its subscription model. Registered readers now have the opportunity to read five articles from our award-winning website for free. Please subscribe for unlimited access.

Print Edition

FinanceAsia Print Edition